- NeuroMetrix (NASDAQ:NURO) announces an agreement with Comprehensive Pain Specialists to offer its Quell device in selected clinic locations. The specialist physician group was formed in 2005 and now has over 60 clinics in 12 states. Financial terms are not disclosed.
- Quell is a wearable neurostimulation device that is worn around the upper calf to provide pain relief due to diabetes, fibromyalgia, arthritis and in the lower back and leg. It is available in the U.S. without a prescription.
NeuroMetrix inks Quell distribution deal with pain specialist group
Recommended For You
More Trending News
About NURO Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
NURO | - | - |
NeuroMetrix, Inc. |